Ipsen
Epizyme’s vision is to rewrite therapy for cancer and other serious diseases through targeted epigenetic medicines. We aspire to change the standard of care for patients and healthcare providers by developing medicines with new mechanisms of action. Our discovery research is yielding exciting new targets for which we are developing novel small molecule programs with the goal of creating a pipeline of clinical candidates. Our exceptional team is wholly dedicated to bringing epigenetic therapies to the many patients who may benefit from them. Lean more at www.epizyme.com.